INTRALESIONAL SCLEROSANT INJECTION FOR WRIST GANGLIA- A CASE SERIES

G. Santhi Vardhani; Mohd Abdul Rehman; Bushra Nishat

Volume : VII, Issue : VI, June - 2018

INTRALESIONAL SCLEROSANT INJECTION FOR WRIST GANGLIA- A CASE SERIES

G. Santhi Vardhani, Mohd Abdul Rehman, Bushra Nishat

Abstract :

Background: Wrist ganglion cases commonly present to a general surgeon with cosmosis and or with symptoms which can be managed by various modes including to wait & watch, surgical and conservative, of which sclerosant therapy is a popular choice. Potential advances in sclerosing agents specific to the treatment of ganglion cysts may lead to a definitive medical treatment of ganglions, which would avoid surgery.

Methods: This study was carried out in Department of General surgery, Osmania Medical college, Hyderabad, Telangana between June, 2017 to December, 2017.Fifteen patients with clinical diagnosis of wrist ganglion;whose age, sex, site of the cyst, any previous treatment taken were recorded. All patients were explained about the lesion and their treatment plan. Three follow-up visitswere performed for upto three months after treatment. Treatment failure being defined as persistence ofswelling at final visitand orpresence of burning sensation and pain.

Result:73%(n=11) ganglion cysts disappeared in single session ofsclerotherapy and rest of 27%(n=4) underwent additonal sclerotherapy session. All ganglion cysts had disappeared by final followup at 3 months. One patients had complications with local pain for 1 month after injection.

Conclusion:Intralesional injection of sclerosant (sodium tetradecyl sulphate), may be considered as a economical, convenient, less invasive and safer alternative to surgical excision of wrist ganglion cysts.